OpenLegislation

Regulation 16 Investigation of certificationF2F1

England and Wales Repealed

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annotations

Textual amendments

F1

Regs. 15-18 omitted (E.) (1.4.2004) by virtue of The General Medical Services and Personal Medical Services Transitional and Consequential Provisions Order 2004 (S.I. 2004/865), art. 1(1), Sch. 1 para. 10(j) (with arts. 94-104); and omitted (W.) (1.4.2004) by virtue of The General Medical Services Transitional and Consequential Provisions (Wales) (No. 2) Order 2004 (S.I. 2004/1016), art. 1(1), Sch. 1 para. 10(1)(j) (with arts. 71, 72, 75(1)–(3), 76-79)

F2

Regulations revoked (E.) by The National Health Service (Pharmaceutical Services) Regulations 2012 (S.I. 2012/1909), reg. 1, Sch. 8 para. 1(1)(a)

Notes on Part II

Modifications

C1

Pt. II applied in part (1.10.2020) by The National Health Service (Pharmaceutical Services) (Wales) Regulations 2020 (S.I. 2020/1073), reg. 1(2), Sch. 5 para. 2(c)

C2

Pt. II applied in part (1.10.2020) by The National Health Service (Pharmaceutical Services) (Wales) Regulations 2020 (S.I. 2020/1073), reg. 1(2), Sch. 6 para. 1(c)

C3

Pt. II applied in part (1.10.2020) by The National Health Service (Pharmaceutical Services) (Wales) Regulations 2020 (S.I. 2020/1073), reg. 1(2), Sch. 7 para. 2(c)

C4

Pt. II applied in part (20.10.2023) by The National Health Service (Ophthalmic Services) (Wales) Regulations 2023 (S.I. 2023/1053), reg. 1(2), Sch. 4 para. 1(1)(d)